This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JEROME ROTSTEIN, M.D.; PAUL S. FRICK, M.D.; BURTRUM C. SCHIELE, M.D.

AMA Arch Intern Med. 1955;96(6):781-786.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Chlorpromazine is proving to be a valuable adjunct in the therapy of many psychiatric and medical disorders. The possibility that occasional persons may develop agranulocytosis while being treated with this drug is not as widely appreciated as it might be.

Chlorpromazine has been used at the University of Minnesota hospitals since the spring of 1954; during this time several hundred patients have received this medication for one or another reason. In addition to those cases in which chlorpromazine was prescribed by us we have seen many patients who have tried this medication before they were referred to us.

The following is our only case so far encountered who has developed agranulocytosis.

REPORT OF A CASE

A 52-year-old white woman was referred to us for the first time on Feb. 1, 1955. She gave a history of becoming increasingly tense and nervous for several months. For a month prior to seeing . . . [Full Text PDF of this Article]

Author Affiliations
Minneapolis

Footnotes
Submitted for publication July 27, 1955.

University of Minnesota Hospitals: Fellow in Internal Medicine, Department of Internal Medicine (Dr. Rotstein); Instructor, Department of Internal Medicine (Dr. Frick); Professor, Department of Psychiatry (Dr. Schiele).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?